A Study to Evaluate the Effects of Giving Proleukin (rIL-2) to HIV-Positive Patients With CD4 Counts Greater Than 300 Cells/mm3
Clinical trial NCT00000949 · COMPLETED
Trial details
- NCT number
- NCT00000949
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Enrollment
- 460
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.